I just got caught up, but I'll take a swing, and o
Post# of 36537
(Total Views: 285)
Posted On: 02/02/2021 6:01:34 PM
I just got caught up, but I'll take a swing, and others feel free to correct me.
1) Joe retired ~3/4 of the NGIO shares. GNBT got 100k shares of preferred shares that appear to be voting only (3000 votes each), as they say they have "no dividend, liquidation or conversion rights and are not subject to redemption".
That means GNBT will always have the 300MM votes for those shares plus how ever many of the ~64MM shares they hold on to after the IPO. So they will have voting control until such time as many more shares have been issued that could wrest that control from them (way, way, way down the road, presumably).
But these shares do not actually have any value or % ownership in NGIO.
2) That means that our ~36MM div shares actually have a huge %ownership in the company (roughly 36%!!! Thanks, Joe!!!).
3) Joe will presumably IPO how ever many shares at ~$5 to raise what he needs to get the parts moving. I would guess he would limit that to as few as possible for now, since he will expect the SP to rise after the IPO. Also, the fewer shares he IPOs, the smaller the float and the more stable the post-IPO price.
So maybe he IPOs 20MM shares, as I believe Bwolfy suggested. That gives him ~$100MM working capital to move forward.
4) Joe could sell further shares on the open market later if he needs to raise further cash. And if there is any vaccine or other partnership success, he will be able to raise more per share. So I wonder if he might IPO a smaller amount initially and wait for that rise.
5) If the deals and their (what I will dub secondary, since they require vaccine approval) "up front" payments come in, that will be substantial for us as shareholders. For example, the China deal is set to pay $50MM upon approval. If that comes thru, that is ~$0.50/sh in cash on the books for NGIO. Pretty substantial.
And just imagine if there is vaccine success leading to purchases at $1.50-$2.50/dose. That adds up quickly. '
6) I wonder what this means for the IPO time frame? The fact that this move was made already makes me think things are in the works. I know Joe said in one of the videos that by Mid-March the IPO would happen. But I really feel that, with this move, it could very well be some time in Feb.
All in all, this seems like a creative piece of Finance work that not only enables the IPO, but also gets cash for Joe to start to develop the businesses... and provides substantial value to shareholders.
This is getting exciting!!! Great job, Joe!!!
1) Joe retired ~3/4 of the NGIO shares. GNBT got 100k shares of preferred shares that appear to be voting only (3000 votes each), as they say they have "no dividend, liquidation or conversion rights and are not subject to redemption".
That means GNBT will always have the 300MM votes for those shares plus how ever many of the ~64MM shares they hold on to after the IPO. So they will have voting control until such time as many more shares have been issued that could wrest that control from them (way, way, way down the road, presumably).
But these shares do not actually have any value or % ownership in NGIO.
2) That means that our ~36MM div shares actually have a huge %ownership in the company (roughly 36%!!! Thanks, Joe!!!).
3) Joe will presumably IPO how ever many shares at ~$5 to raise what he needs to get the parts moving. I would guess he would limit that to as few as possible for now, since he will expect the SP to rise after the IPO. Also, the fewer shares he IPOs, the smaller the float and the more stable the post-IPO price.
So maybe he IPOs 20MM shares, as I believe Bwolfy suggested. That gives him ~$100MM working capital to move forward.
4) Joe could sell further shares on the open market later if he needs to raise further cash. And if there is any vaccine or other partnership success, he will be able to raise more per share. So I wonder if he might IPO a smaller amount initially and wait for that rise.
5) If the deals and their (what I will dub secondary, since they require vaccine approval) "up front" payments come in, that will be substantial for us as shareholders. For example, the China deal is set to pay $50MM upon approval. If that comes thru, that is ~$0.50/sh in cash on the books for NGIO. Pretty substantial.
And just imagine if there is vaccine success leading to purchases at $1.50-$2.50/dose. That adds up quickly. '
6) I wonder what this means for the IPO time frame? The fact that this move was made already makes me think things are in the works. I know Joe said in one of the videos that by Mid-March the IPO would happen. But I really feel that, with this move, it could very well be some time in Feb.
All in all, this seems like a creative piece of Finance work that not only enables the IPO, but also gets cash for Joe to start to develop the businesses... and provides substantial value to shareholders.
This is getting exciting!!! Great job, Joe!!!
(8)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼